Featured
The Metabolic Recalibration: How FDA Crackdowns and GLP-1 Sarcopenia Are Restructuring the Fitness Economy
The FDA's October 2026 enforcement action against unregulated peptide labs, combined with clinical data on GLP-1 induced sarcopenia, is forcing a comp...
Read Full Story →